Summary
The product Proviron, containing Mesterolone, underwent independent testing to verify its authenticity and potency. The sample was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control.
The analysis measured the presence of Mesterolone, with a concentration of 27.70 mg, though no labeled claim or reference specification was provided due to unknown manufacturer and batch details.
The testing process began on 2 May 2024, with the sample received on 7 May 2024, and analysis completed on 10 May 2024. The lack of batch and manufacturer information limits direct comparison with standard specifications, emphasizing the need for careful evaluation of product authenticity and consistency. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unknown
- Product Name: Mesterolone
- Active Ingredient: Mesterolone
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #41897
- Testing Ordered: 2 May 2024
- Sample Received: 7 May 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: ACE Pharmaceuticals (Manufacturer)
- Analysis Paid For By: ACE Pharmaceuticals (Manufacturer)
Testing Results
- Specification: 25mg
- Measured Concentration: 27.70 mg of Mesterolone
- Accuracy: 110.80%
- Variance: 10.80%
Verification Details
- Verification URL: https://janoshik.com/tests/41897_QBJ6U8ENHJ3W
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the presence of Mesterolone in the tested sample but raises concerns due to the lack of manufacturer and batch details. Without this information, it is challenging to confirm consistency across different product sources.
While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches to ensure product authenticity.
Conclusion
The analysis confirms that Proviron contains Mesterolone at 27.70 mg, but due to the absence of a labeled claim, manufacturer, and batch details, further verification is needed. This underscores the importance of additional testing to ensure consistent dosing and authenticity across different product sources.
This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
